CRYSTAL ZEHNAL: Open Payments
NPI 1225530306 · FAIRLAWN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $99 · 2025 $180
Food & beverage: $123Education: $57
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $57 |
| Optinose US, Inc. | 2 | $42 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Amgen Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: DUPIXENT, Xhance, TEZSPIRE, NUCALA.
Industry payments across OH — which companies pay providers there.
